Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
about
Devices in the management of advanced, chronic heart failureGenetic bases of arrhythmogenic right ventricular CardiomyopathySubclinical markers of cardiovascular disease predict adverse outcomes in chronic kidney disease patients with normal left ventricular ejection fraction.Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.Adrenal adenoma presenting with torsade de pointes--a case report.Intramyocardial fibroblast myocyte communication.Hypertension: an important precursor of heart failure.Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice.Primary prevention of heart failure.From hypertension to heart failure -- are there better primary prevention strategies?Optimal medical treatment of cardiovascular risk factors: can we prevent the development of heart failure?Massively dilated right atrium masquerading as a mediastinal tumor.Aldosterone antagonists in heart failure.Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.Heart failure in hypertension: prevention and treatment.Cardiac myocyte-fibroblast interactions and the coronary vasculature.Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapy.Comparison of Left Ventricular Hypertrophy, Fibrosis and Dysfunction According to Various Disease Mechanisms such as Hypertension, Diabetes Mellitus and Chronic Renal Failure.TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.Lack of rapid aldosterone effects on forearm resistance vasculature in health.The association between left ventricular global longitudinal strain, renal impairment and all-cause mortality.Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure.Dietary salt exacerbates isoproterenol-induced cardiomyopathy in rats.Pro-inflammation and pro-fibrosis factors were highly induction in heart tissues of carotid arteries balloon-injured animal model.Physiological regulation of extracellular matrix collagen and elastin in the arterial wall of rats by noradrenergic tone and angiotensin II.
P2860
Q24630052-C765BE67-3DE0-4128-977C-36447BF17865Q28249805-1DCDA761-DBFE-49DD-A75B-93DE9F62AF25Q30358332-2E4B7474-3852-4E57-A8D6-BA3DCBE640B3Q30479528-9F82B1B3-55ED-487D-9054-6A9EB400E367Q33147935-A5891F9B-25D9-49A4-BA9E-8B81FC8EA2E9Q33586605-59ED116D-48F4-4D25-AF4C-965875FA84FDQ33913917-59826ACF-0D1D-4D2C-80AC-5A7780D6DCD2Q35083462-9B5F9EA2-FECB-48D4-953F-DFD230149849Q36200030-BB78FD61-FF60-403A-AFC0-B414F6934323Q36643663-1332D7BA-347F-4A1C-BFC8-20ACBAAF19A8Q37390750-B9DE725E-84D2-4D23-9A36-5A87AF8BCEC0Q37694127-EF3CA8C8-B1B9-450B-888A-A2764143BDCBQ37821172-63A78569-D5B4-416D-BABF-8205262FBF03Q37867324-E4B4DF2D-8BFA-421D-B618-40C312BA450AQ37969775-53DAA721-22D6-4DBC-B6B9-69ED5F7A9042Q38022713-A80AE50D-5F85-4179-8324-ED54CD1E793DQ38044304-B8BDE058-6F78-4B12-917F-505DD2DE0FAFQ39693574-4E81E3CF-5D5F-4B63-AD81-950C3AF1A884Q41036688-33EEEB3A-6363-4466-81FC-57E08437D778Q41253251-FD2B000F-041A-4818-84EA-2560002EE549Q42639607-D24EC358-BA7D-4BC7-B66C-AE1BF78EBF1BQ44135253-2C8F25D9-08B2-4AC3-8FE8-F8D8BE6AD012Q45825542-9F82A548-1710-4342-8695-B21CF2BC72D9Q47265303-900FFC13-A5DB-4284-89EB-29B6ECC71F26Q48925509-F2E35536-4DD5-4368-996C-AAD12F98686FQ50250277-0C846ED4-4DD2-441C-B44A-DF9EB1C757BBQ54361247-1CB69C0C-B24C-4845-BBB1-BF0C1354ACF8
P2860
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@ast
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@en
type
label
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@ast
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@en
prefLabel
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@ast
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@en
P2093
P2860
P1433
P1476
Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure.
@en
P2093
P2860
P356
10.3109/08037059209077497
P577
1992-08-01T00:00:00Z